Unknown

Dataset Information

0

Akkermansia muciniphila ameliorates the age-related decline in colonic mucus thickness and attenuates immune activation in accelerated aging Ercc1 -/?7 mice.


ABSTRACT: Background:The use of Akkermansia muciniphila as potential therapeutic intervention is receiving increasing attention. Health benefits attributed to this bacterium include an improvement of metabolic disorders and exerting anti-inflammatory effects. The abundance of A. muciniphila is associated with a healthy gut in early mid- and later life. However, the effects of A. muciniphila on a decline in intestinal health during the aging process are not investigated yet. We supplemented accelerated aging Ercc1 -/?7 mice with A. muciniphila for 10?weeks and investigated histological, transcriptional and immunological aspects of intestinal health. Results:The thickness of the colonic mucus layer increased about 3-fold after long-term A. muciniphila supplementation and was even significantly thicker compared to mice supplemented with Lactobacillus plantarum WCFS1. Colonic gene expression profiles pointed towards a decreased expression of genes and pathways related to inflammation and immune function, and suggested a decreased presence of B cells in colon. Total B cell frequencies in spleen and mesenteric lymph nodes were not altered after A. muciniphila supplementation. Mature and immature B cell frequencies in bone marrow were increased, whereas B cell precursors were unaffected. These findings implicate that B cell migration rather than production was affected by A. muciniphila supplementation. Gene expression profiles in ileum pointed toward a decrease in metabolic- and immune-related processes and antimicrobial peptide production after A. muciniphila supplementation. Besides, A. muciniphila decreased the frequency of activated CD80+CD273- B cells in Peyer's patches. Additionally, the increased numbers of peritoneal resident macrophages and a decrease in Ly6Cint monocyte frequencies in spleen and mesenteric lymph nodes add evidence for the potentially anti-inflammatory properties of A. muciniphila. Conclusions:Altogether, we show that supplementation with A. muciniphila prevented the age-related decline in thickness of the colonic mucus layer and attenuated inflammation and immune-related processes at old age. This study implies that A. muciniphila supplementation can contribute to a promotion of healthy aging.

SUBMITTER: van der Lugt B 

PROVIDER: S-EPMC6408808 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

<i>Akkermansia muciniphila</i> ameliorates the age-related decline in colonic mucus thickness and attenuates immune activation in accelerated aging <i>Ercc1</i> <sup><i>-/Δ7</i></sup> mice.

van der Lugt Benthe B   van Beek Adriaan A AA   Aalvink Steven S   Meijer Ben B   Sovran Bruno B   Vermeij Wilbert P WP   Brandt Renata M C RMC   de Vos Willem M WM   Savelkoul Huub F J HFJ   Steegenga Wilma T WT   Belzer Clara C  

Immunity & ageing : I & A 20190308


<h4>Background</h4>The use of <i>Akkermansia muciniphila</i> as potential therapeutic intervention is receiving increasing attention. Health benefits attributed to this bacterium include an improvement of metabolic disorders and exerting anti-inflammatory effects. The abundance of <i>A. muciniphila</i> is associated with a healthy gut in early mid- and later life. However, the effects of <i>A. muciniphila</i> on a decline in intestinal health during the aging process are not investigated yet. We  ...[more]

Similar Datasets

2019-02-20 | GSE126730 | GEO
| PRJNA523132 | ENA
2022-12-31 | GSE214253 | GEO
| S-EPMC5902328 | biostudies-literature
| S-EPMC5103097 | biostudies-literature
| PRJEB31523 | ENA
2016-10-19 | GSE87368 | GEO